PRAMIRACETAM SULFATE

Product Name: PRAMIRACETAM SULFATE

Synonyms: PRAMIRACETAM SULFATE;Pramiracetam sulphate;Amacetam sulfate;CI-879;N-[2-[Bis(1-methylethyl)amino]ethyl]-2-oxo-1-pyrrolidineacetamide sulfate;1-PyrrolidineacetaMide, N-(2-(bis(1-Methylethyl)aMino)ethyl)-2-oxo-;N-(2-(Diisopropylamino)ethyl)-2-(2-oxopyrrolidin-1-yl)acetamide sulfate;N-[2-(Diisopropylamino)ethyl]-2-(2-oxopyrrolidin-1-yl)acetamide

CAS: 72869-16-0

MF: C14H27N3O2.H2O4S

MW: 367.464

EINECS:

Product Categories: Health supplements;APIS;Brain health drug;Nootropic

Mol File: 72869-16-0.mol

PRAMIRACETAM SULFATE Structure

PRAMIRACETAM SULFATE Chemical Properties

Safety Information

Toxicity LD50 in male, female mice (mg/kg): 5434, 4355 orally (Poschel)

MSDS Information

PRAMIRACETAM SULFATE Usage And Synthesis

Description Pramiracetam sulfate, together with aniracetam are two nootropics of the piracetam family introduced in 1993 for the treatment of attention and memory disorders resulting from degenerative or vascular disorders in the elderly. In patients with mild to moderate primary degenerative dementia, treatment with 75-300 mg/day of pramiracetam reduced depression,anxiety, sleep disturbance, and hostility with no observable adverse reactions. Significant improvement of performance on measures of memory, especially delayed recall, have been observed for pramiracetam treated patients with brain injury.

Originator Warner-Lambert (U.S.A.)

Uses Cognition adjuvant.

Brand name Remen; Neupramir; Prarnistar